These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
137 related articles for article (PubMed ID: 2110437)
21. A randomized trial of short-course ciprofloxacin, ofloxacin, or trimethoprim/sulfamethoxazole for the treatment of acute urinary tract infection in women. Ciprofloxacin Urinary Tract Infection Group. McCarty JM; Richard G; Huck W; Tucker RM; Tosiello RL; Shan M; Heyd A; Echols RM Am J Med; 1999 Mar; 106(3):292-9. PubMed ID: 10190377 [TBL] [Abstract][Full Text] [Related]
22. Fleroxacin versus norfloxacin in the treatment of urinary tract infections: a multicenter, double-blind, prospective, randomized, comparative study. Pummer K Am J Med; 1993 Mar; 94(3A):108S-113S. PubMed ID: 8452165 [TBL] [Abstract][Full Text] [Related]
23. Ciprofloxacin 250 mg twice daily versus ofloxacin 200 mg twice daily in the treatment of complicated urinary tract infections in women. Raz R; Naber KG; Raizenberg C; Rohana Y; Unamba-Oparah I; Korfman G; Yaniv I Eur J Clin Microbiol Infect Dis; 2000 May; 19(5):327-31. PubMed ID: 10898131 [TBL] [Abstract][Full Text] [Related]
24. Randomized, controlled trial of a 10-day course of amifloxacin versus trimethoprim-sulfamethoxazole in the treatment of acute, uncomplicated urinary tract infection. Amifloxacin Multi-Center Trial Group. Boyko EJ; Iravani A; Silverman MH; Schelling DJ; Wright RA Antimicrob Agents Chemother; 1990 Apr; 34(4):665-7. PubMed ID: 2188590 [TBL] [Abstract][Full Text] [Related]
25. A randomized, double-blind, multicenter comparison of gatifloxacin versus ciprofloxacin in the treatment of complicated urinary tract infection and pyelonephritis. Cox CE; Marbury TC; Pittman WG; Brown GL; Auerbach SM; Fox BC; Yang JY Clin Ther; 2002 Feb; 24(2):223-36. PubMed ID: 11911553 [TBL] [Abstract][Full Text] [Related]
26. Fleroxacin versus norfloxacin for oral treatment of serious urinary tract infections. Childs SJ Am J Med; 1993 Mar; 94(3A):105S-107S. PubMed ID: 8452164 [TBL] [Abstract][Full Text] [Related]
27. Fleroxacin. A review of its pharmacology and therapeutic efficacy in various infections. Balfour JA; Todd PA; Peters DH Drugs; 1995 May; 49(5):794-850. PubMed ID: 7601015 [TBL] [Abstract][Full Text] [Related]
28. Once daily, extended release ciprofloxacin for complicated urinary tract infections and acute uncomplicated pyelonephritis. Talan DA; Klimberg IW; Nicolle LE; Song J; Kowalsky SF; Church DA J Urol; 2004 Feb; 171(2 Pt 1):734-9. PubMed ID: 14713799 [TBL] [Abstract][Full Text] [Related]
29. Quinolones in everyday clinical practice: respiratory tract infections and nosocomial pneumonia. Marklein G Chemotherapy; 1996 Mar; 42 Suppl 1():33-42. PubMed ID: 8861533 [TBL] [Abstract][Full Text] [Related]
30. Safety of fleroxacin coadministered with theophylline to young and elderly volunteers. Parent M; St-Laurent M; LeBel M Antimicrob Agents Chemother; 1990 Jun; 34(6):1249-53. PubMed ID: 2118328 [TBL] [Abstract][Full Text] [Related]
31. Dose-ranging study of fleroxacin for treatment of uncomplicated Chlamydia trachomatis genital infections. Bowie WR; Willetts V; Megran DW Antimicrob Agents Chemother; 1989 Oct; 33(10):1774-7. PubMed ID: 2511801 [TBL] [Abstract][Full Text] [Related]
32. Comparative efficacy of sparfloxacin versus ciprofloxacin in the treatment of complicated urinary tract infection. Naber KG; di Silverio F; Geddes A; Guibert J J Antimicrob Chemother; 1996 May; 37 Suppl A():135-44. PubMed ID: 8737133 [TBL] [Abstract][Full Text] [Related]
33. Efficacy and safety of a novel once-daily extended-release ciprofloxacin tablet formulation for treatment of uncomplicated urinary tract infection in women. Fourcroy JL; Berner B; Chiang YK; Cramer M; Rowe L; Shore N Antimicrob Agents Chemother; 2005 Oct; 49(10):4137-43. PubMed ID: 16189090 [TBL] [Abstract][Full Text] [Related]
34. Once Daily Fleroxacin and Twice Daily Ciprofloxacin are Both Effective in the Treatment of Complicated Urinary Tract Infections. Guimarães T; Rios LA; Mendes W; Brandina L; Silva NF; Bastos C; Alcântara AP; Levi G Braz J Infect Dis; 1997 Apr; 1(2):77-82. PubMed ID: 11107243 [TBL] [Abstract][Full Text] [Related]
35. A double-blind, randomized comparison of levofloxacin 750 mg once-daily for five days with ciprofloxacin 400/500 mg twice-daily for 10 days for the treatment of complicated urinary tract infections and acute pyelonephritis. Peterson J; Kaul S; Khashab M; Fisher AC; Kahn JB Urology; 2008 Jan; 71(1):17-22. PubMed ID: 18242357 [TBL] [Abstract][Full Text] [Related]
36. Comparison of once-daily extended-release ciprofloxacin and conventional twice-daily ciprofloxacin for the treatment of uncomplicated urinary tract infection in women. Henry DC; Bettis RB; Riffer E; Haverstock DC; Kowalsky SF; Manning K; Hamed KA; Church DA Clin Ther; 2002 Dec; 24(12):2088-104. PubMed ID: 12581547 [TBL] [Abstract][Full Text] [Related]
37. Current issues in the management of urinary tract infections: extended-release ciprofloxacin as a novel treatment option. Blondeau JM Drugs; 2004; 64(6):611-28. PubMed ID: 15018591 [TBL] [Abstract][Full Text] [Related]
38. Acute, uncomplicated, lower urinary tract infections: the role of single-dose fleroxacin. Kosmidis J; Gargalianos P; Lelekis M; Adamis G; Petropoulou D; Makris D J Chemother; 1989 Jul; 1(4 Suppl):864-5. PubMed ID: 16312675 [No Abstract] [Full Text] [Related]
39. Short-course ciprofloxacin treatment of acute uncomplicated urinary tract infection in women. The minimum effective dose. The Urinary Tract Infection Study Group [corrected]. Iravani A; Tice AD; McCarty J; Sikes DH; Nolen T; Gallis HA; Whalen EP; Tosiello RL; Heyd A; Kowalsky SF Arch Intern Med; 1995 Mar; 155(5):485-94. PubMed ID: 7864704 [TBL] [Abstract][Full Text] [Related]
40. Single and multiple dose pharmacokinetics of fleroxacin. Weidekamm E; Portmann R; Partos C; Dell D J Antimicrob Chemother; 1988 Oct; 22 Suppl D():145-54. PubMed ID: 3144533 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]